Plasma pentraxin-3 levels as a diagnostic marker of patients with colorectal cancer: A systematic review and meta-analysis

Indian J Gastroenterol. 2024 Jun 7. doi: 10.1007/s12664-024-01612-3. Online ahead of print.

Kamil Safiejko¹, Michal Pruc^{2

3}, Kacper Dziedzic⁴, Anna Drozd⁵, Magdalena Bizon⁶, Lukasz Szarpak^{1

4

7}

¹ Colorectal Cancer Unit, Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland.
² Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland. [email protected].
³ Department of Public Health, International European University, Kiev, Ukraine. [email protected].
⁴ Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
⁵ Department of Oncology, Centre of Postgraduate Medical Education, European Health Centre, Otwock, Poland.
⁶ Department of Gynecology and Gynecologic Oncology, LUX MED Oncology Hospital, Warsaw, Poland.
⁷ Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.

No abstract available

Publication types